논문KCI 등재
A need for patient-centered care in managing patients with liver cirrhosis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
참고문헌 (18)
- D’Amico G, "Clinical states of cirrhosis and competing risks", J Hepatol, 68, pp.563~576 (2018)
- Peng JK, "Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis", Palliat Med, 33, pp.24~36 (2019)
- Perng CL, "Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study", PLoS One, 9, pp.e88721~ (2014)
- Verma M, "Nonhospice palliative care within the treatment of end-stage liver disease", Hepatology, 71, pp.2149~2159 (2020)
- Suk-Yong Jang, "Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study", Clinical and Molecular Hepatology, 27(2), pp.283~294 (2021), 대한간학회[DOI]
- Ko FY, "Physiologic and laboratory correlates of depression, anxiety, and poor sleep in liver cirrhosis", BMC Gastroenterol, 13, pp.18~ (2013)
- Zhu HP, "Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis", Exp Ther Med, 12, pp.405~409 (2016)
- Ko FY, "Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis", Int J Psychiatry Med, 45, pp.15~29 (2013)
- Xu H, "Female gender and gastrointestinal symptoms, not brain-derived neurotrophic factor, are associated with depression and anxiety in cirrhosis", Hepatol Res, 47, pp.E64~E73 (2017)
- Le Strat Y, "Major depression and suicide attempts in patients with liver disease in the United States", Liver Int, 35, pp.1910~1916 (2015)
- "Deaths according to the 50 etiologies in 2019"[URL]
- "Current state of suicide according to the baseline characteristics in 2019"[URL]
- Huang X, "Depression and insomnia are closely associated with thyroid hormone levels in chronic hepatitis B", Med Sci Monit, 25 (2019)
- Alekseeva AS, "Serotonin metabolism parameters in patients with chronic hepatitis and liver cirrhosis", Bull Exp Biol Med, 146, pp.577~579 (2008)
- Chojnacki C, "Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis", Pol Arch Med Wewn, 122, pp.392~397 (2012)
- Chojnacki C, "Melatonin secretion and metabolism in patients with hepatic encephalopathy", J Gastroenterol Hepatol, 28, pp.342~347 (2013)
- Lee KT, "Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma: a nationwide study of a cohort from Taiwan", World J Biol Psychiatry, 19, pp.431~439 (2018)
- Verma M, "Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial", J Palliat Med, 22, pp.34~43 (2019)
관련 논문AI추천
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than everMarta Tonon, Salvatore Piano대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health SystemsBernd E. Schnabl, Michael E. Matheny, Samuel B. Ho거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Acute on chronic liver failure in cirrhosisMarta Tonon, Salvatore Piano대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제2호Management of liver diseases during the pandemic of coronavirus disease-19송도선, Jeong Hoon Lee, Ji Hoon Kim, Ju-Yeon Cho, Korean Association for the Study of the Liver, Soon Sun Kim, Young-Sun Lee대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제3호From invasive to intuitive: The emerging role of noninvasive models in hepatic decompensation: Editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”Akhil Deshmukh, Rakhi Maiwall대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of greySusana G. Rodrigues대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호
이 간행물의 다른 논문 (14건)
Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseDonghee Kim, Aijaz Ahmed, Wijarnpreecha Karn, Elizabeth S. Abypp. 221-235Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospectsHideki Iwamoto, Takuji Torimurapp. 236-245Current and future strategies for the treatment of chronic hepatitis COmar Alshuwaykh, Paul Y. Kwopp. 246-256From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?Korean NAFLD Study Group, Yuri Cho, Soung Won Jeong, Jin-Woo Lee, Seong Hee Kang, Seung Up Kimpp. 257-269Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or factGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yippp. 273-277
